HIGHLIGHTS
- who: Satoshi Tamada from the Department of Urology, Bell Land General Hospital, Japan, u2011, have published the article: Prognostic value of PD-L1 expression in recurrent renal cell carcinoma after nephrectomy: a secondary analysis of the ARCHERY study, in the Journal: (JOURNAL)
- what: Clinical stage was used instead of T stage because information on T stage was not collected in ARCHERY since the study focused on OS after 1L treatment of recurrent or metastatic RCC.
- how: Showed that PD-L1 expression was not an independent prognostic marker after first-line (1L) treatment because . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.